Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
---|
07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
07/09/2003 | EP1072588B1 Process for producing arylsulfenyl halide |
07/09/2003 | CN1429210A Substituted thioacetamides |
07/09/2003 | CN1429209A Disulfide derivatives useful for treating allergic diseases |
07/09/2003 | CN1429208A Aniline disulfide derivatives for treating allergic diseases |
07/09/2003 | CN1429199A Insecticidal 1,8-naphthalenedicarboxamides |
07/09/2003 | CN1429198A Novel phenyl-proparylether derivatives |
07/09/2003 | CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
07/09/2003 | CN1113870C Preparation of butylthio-isoquinoline and intermediate thereof |
07/08/2003 | US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) |
07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
07/08/2003 | US6589976 Particularly effective wood preservation is achieved by impregnation processes on a large industrial scale, for example vacuum, a double vacuum or pressure processes. |
07/08/2003 | CA2280395C New hydroxamic acid derivatives, their preparation process and the pharmaceutical compositions which contain them |
07/08/2003 | CA2059821C 2,5-dichlorophenylthioglycolic acid derivative and method for its production |
07/03/2003 | WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
07/03/2003 | WO2003053910A1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of nmr structural analysis of protein and process for producing site-selective stable isotope-labeled fumaric acid and tartaric acid |
07/03/2003 | WO2003053891A1 Trimerisation and oligomerisation of olefins using a chromium based catalyst |
07/03/2003 | WO2003053890A1 Trimerisation and oligomerisation of olefins using a chromium based catalyst |
07/03/2003 | US20030125579 Aliphatic amines, alicyclic amines, and aralkyl aminea are reacted with alkylaryl carbonates to produce carbamates which are thermally decomposed to produce isocyanates |
07/03/2003 | US20030125362 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
07/03/2003 | US20030125329 Treating atherosclerosis and other coronary artery diseases |
07/03/2003 | US20030125328 Treating atherosclerosis and other coronary artery diseases |
07/03/2003 | US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software |
07/03/2003 | US20030124053 Radiopharmaceuticals for imaging infection and inflammation |
07/02/2003 | EP1323708A1 Method for producing carbamates and method for producing isocyanates |
07/02/2003 | EP1322603A1 Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl- and heteroarylsulfonyl-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds |
07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
07/02/2003 | EP1322597A1 Process and intermediates |
07/02/2003 | EP1322331A2 Fatty acid synthase inhibitors |
07/01/2003 | US6586623 Thiol-based NAALADase inhibitors |
07/01/2003 | US6586617 Sulfonamide derivatives |
07/01/2003 | US6586611 Zinc-monocysteine complex and method of using zinc-cysteine complexes |
07/01/2003 | US6586600 For removing metals from soils, water; pollution control; form stable, irreversible ligand-metal precipitates |
07/01/2003 | US6586519 Thioether substituted hydroxybenzophenones and stabilized compositions |
07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
07/01/2003 | US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders |
06/26/2003 | WO2003051893A2 Improvements in pharmaceutical compositions |
06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051827A1 Process for the preparation of an enantiomerically enriched thio compound |
06/26/2003 | WO2003051826A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
06/26/2003 | WO2003051823A1 Beta-amino-alpha-cyanoacrylates and their use as herbicides |
06/26/2003 | WO2003051807A2 Improvements in pharmaceutical compositions |
06/26/2003 | WO2003051348A2 Composition, synthesis and therapeutic applications of polyamines |
06/26/2003 | US20030120032 N-methyl-homocysteines and their use as well as process for their production |
06/26/2003 | US20030119902 Novel aminobenzoephenones |
06/26/2003 | US20030119876 Compounds for the treatment of protozoal diseases |
06/26/2003 | US20030119833 Treating cardiovascular diseases |
06/26/2003 | US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties. |
06/26/2003 | US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors |
06/26/2003 | US20030119152 Substituted 2-amino-3- (2-amino-phenylsulfanyl) -propionic acids |
06/26/2003 | US20030119054 Polypeptide immobilization |
06/26/2003 | US20030118877 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators |
06/26/2003 | US20030118729 Gold nanoparticles |
06/26/2003 | CA2510128A1 Composition, synthesis and therapeutic applications of polyamines |
06/26/2003 | CA2470156A1 .beta.-amino-.alpha.-cyanoacrylates and their use as herbicides |
06/26/2003 | CA2470060A1 Improvements in pharmaceutical compositions |
06/26/2003 | CA2469976A1 Improvements in pharmaceutical compositions |
06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/25/2003 | EP1321460A2 Surfactant composition and method of making the same |
06/25/2003 | EP1235792A4 Preparation of [4s-(4alpha,7alpha,10abeta)]-4-amino-octahydro-5-oxo-7h-pyrido 2,1-b] 1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides |
06/25/2003 | EP0871650B1 Solid phase organic synthesis |
06/25/2003 | CN1426388A Process for preparation of 2-halobenzoic acids |
06/25/2003 | CN1425662A Bucillamine synthesizing novel intermediate 5,5-dimethyl-2-thione-4-one-1-sulfur-3-oxy-hetero pentocyclic |
06/25/2003 | CN1425650A Process for extracting alliin from fresh garlic |
06/25/2003 | CN1425649A Process for preparing mercaptoacetic acid |
06/25/2003 | CN1112356C Nitromethylthiobenzene derivative as inhibitors of aldose reductase |
06/25/2003 | CN1112114C Fodder additive containing zinc hydroxy methionine and preparation method therefor |
06/24/2003 | US6583306 Forming dioxolane derivative of citramalic acid; replacing free carboxylic acid with leaving group; coupling with hydroxyl, amino, thiol, sulphinyl or sulphonyl reactive compound; deprotecting; amidation with aniline derivitive |
06/24/2003 | US6583299 α-amino-β-sulfonyl hydroxamic acid compounds |
06/24/2003 | US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
06/24/2003 | CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant |
06/19/2003 | WO2003050073A1 Substituted hydroxyethylamines |
06/19/2003 | WO2003050071A1 Process for the preparation of methionine |
06/19/2003 | WO2003049702A2 Vanilloid receptor ligands and their use in treatments |
06/19/2003 | WO2003049666A2 Compounds for a controlled release of active molecules |
06/19/2003 | US20030114721 Functionalization is produced by the action of perhalogenated sulphonyl chloride on the carbon bearing sulphur in presence of a free radical initiator, preferably by homolytic cleavage |
06/19/2003 | US20030114681 C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
06/19/2003 | US20030114521 Oxamic acids and derivatives as thyroid receptor ligands |
06/19/2003 | US20030114508 Fused imidazolium derivatives |
06/19/2003 | US20030114490 New phenylalanine derivatives |
06/19/2003 | US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
06/19/2003 | US20030114447 Controlling apoptosis; central nervous system disorders |
06/19/2003 | US20030114435 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient |
06/19/2003 | US20030113792 Epoxide polymer surfaces |
06/19/2003 | CA2469622A1 Substituted hydroxyethylamines |
06/19/2003 | CA2469526A1 Process for the preparation of methionine |
06/19/2003 | CA2468544A1 Vanilloid receptor ligands |
06/19/2003 | CA2468231A1 Compounds for a controlled release of active molecules |
06/18/2003 | EP1318978A2 N-acylsulfonamide apoptosis promoters |
06/18/2003 | EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
06/18/2003 | EP1098874B1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
06/18/2003 | EP1082297B1 Substituted dithio-bis-nitrobenzenes and their applications |
06/18/2003 | EP0946492B1 Novel 2-fluoroacrylic acid derivatives, novel mixtures of herbicides and antidotes and the use thereof |
06/18/2003 | CN1425000A Gold nanoparticles |
06/18/2003 | CN1111524C Process for manufacture of pyridine-2,3-dicarboxylate compounds and intermediates |
06/18/2003 | CN1111520C Matrix metalloprotease inhibitors |